St. Mary Medical Center is the first healthcare provider in Bucks County to offer Aquablation therapy for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Aquablation therapy is an advanced, minimally invasive treatment that uses the power of water delivered with robotic precision to provide best-in-class and long-lasting symptom relief for BPH, with low rates of complications.
BPH, or an enlarged prostate, is a non-cancerous condition where the prostate has grown larger than normal. One in two men ages 51 to 60 have BPH, and the incidence increases every decade of life. If left untreated, BPH can cause significant health problems, including irreversible bladder or kidney damage, bladder stones and incontinence.
BPH surgical treatments often provide symptom relief at the cost of side effects, making patients choose between a high degree of symptom relief with high rates of irreversible complications, such as incontinence, erectile dysfunction or ejaculatory dysfunction; or a low degree of symptom relief with low rates of irreversible complications. Aquablation therapy provides a high degree of symptom relief with low rates of irreversible complications, regardless of prostate size or shape.
“We are proud to be the first in Bucks County to offer a solution for men with BPH that provides BPH relief without compromise,” said Jamison Jaffe, DO, a fellowship training urologist and division chair of Urology for St. Mary Medical Center. “Aquablation therapy is the next step to furthering our commitment to robotic surgery and men’s health. Our goal is to help our community enhance their health using the most advanced technology available.”
Aquablation therapy is performed by the AquaBeam Robotic System, the first FDA-cleared surgical robot that utilizes automated tissue resection for the treatment of LUTS due to BPH. It combines real-time, multi-dimensional imaging, automated robotic technology and heat-free waterjet ablation technology for targeted, controlled and immediate removal of prostate tissue. Aquablation therapy offers predictable and reproducible outcomes, independent of prostate anatomy, prostate size or surgeon experience.
Aquablation therapy has proven results. In clinical studies, Aquablation therapy has shown to provide both best-in-class and durable symptom relief with low rates of irreversible complications. A study in the Journal of Sexual Medicine, which surveyed 300 men living with BPH, revealed 92 percent of respondents expressed an interest in learning more about Aquablation therapy. This data demonstrates a need within the patient population to find relief without the tradeoff between symptoms and relief side effects.
Visit trinityhealthma.org/aquablation for more information.